Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Hero

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
Cancer|September 14, 2022
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning MeetingJulie R Park, Judith G Villablanca, Barbara Hero, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2016
Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patientsEsther M van Wezel, Boris Decarolis, Janine Stutterheim, et al.
Klinische Padiatrie|June 1, 2017
2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic TumorsThorsten Simon, Barbara Hero, Johannes H Schulte, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2010
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group ProjectVeronica Moroz, David Machin, Andreas Faldum, et al.
Frontiers in Oncology|February 8, 2021
Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg RegistryDanny Jazmati, Sarina Butzer, Barbara Hero, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 9, 2022
Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International PerspectiveThomas Rossor, E Ann Yeh, Yasmin Khakoo, et al.
Frontiers in Oncology|March 10, 2025
Risk stratification in neuroblastoma patients through machine learning in the multicenter PRIMAGE cohortJose Lozano-Montoya, Ana Jimenez-Pastor, Almudena Fuster-Matanzo, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2016
Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group ProjectMark A Applebaum, Zalman Vaksman, Sang Mee Lee, et al.
Pediatric Blood & Cancer|May 6, 2015
Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastomaEsther M van Wezel, Janine Stutterheim, Florentien Vree, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 25, 2024
Sensitive liquid biopsy monitoring correlates with outcome in the prospective international GPOH-DCOG high-risk neuroblastoma RT-qPCR validation studyLieke M J van Zogchel, Boris Decarolis, Esther M van Wezel, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Cancer|September 14, 2022
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning MeetingJulie R Park, Judith G Villablanca, Barbara Hero, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2016
Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patientsEsther M van Wezel, Boris Decarolis, Janine Stutterheim, et al.
Klinische Padiatrie|June 1, 2017
2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic TumorsThorsten Simon, Barbara Hero, Johannes H Schulte, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2010
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group ProjectVeronica Moroz, David Machin, Andreas Faldum, et al.
Frontiers in Oncology|February 8, 2021
Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg RegistryDanny Jazmati, Sarina Butzer, Barbara Hero, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 9, 2022
Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International PerspectiveThomas Rossor, E Ann Yeh, Yasmin Khakoo, et al.
Frontiers in Oncology|March 10, 2025
Risk stratification in neuroblastoma patients through machine learning in the multicenter PRIMAGE cohortJose Lozano-Montoya, Ana Jimenez-Pastor, Almudena Fuster-Matanzo, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2016
Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group ProjectMark A Applebaum, Zalman Vaksman, Sang Mee Lee, et al.
Pediatric Blood & Cancer|May 6, 2015
Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastomaEsther M van Wezel, Janine Stutterheim, Florentien Vree, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 25, 2024
Sensitive liquid biopsy monitoring correlates with outcome in the prospective international GPOH-DCOG high-risk neuroblastoma RT-qPCR validation studyLieke M J van Zogchel, Boris Decarolis, Esther M van Wezel, et al.
Pageof 15